Michael Triplett, Myonexus Therapeutics (IMAGE) CincyTech Caption Thiis is Michael Triplett, PhD, CEO, Myonexus Therapeutics. Credit Myonexus Therapeutics Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.